Back to UBS Group AG UBS Group AG

CABACABA
Showing 8 of 25 quarters

Position history for UBS Group AGUBS Group AG's holdings in Cabaletta Bio, Inc.

UBS Group AG holds 1.5M shares of CABA (Cabaletta Bio, Inc.), worth $4.6M as of 2026-Q2. The position was increased (+142.6% shares). CABA represents 0.0% of UBS Group AG's portfolio.

Current Value

$4.6M

Current Shares

1.5M

Total Value Change

+$4.5M

Total Shares Change

+1.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.5M
+142.6%
$4.6M0.0%$3.11
43
2026-Q1
Increased
606,664
+46.0%
$1.6M0.0%$3.25
35
2025-Q4
Increased
415,677
+2.6%
$910,3330.0%$2.15
26
2025-Q3
Decreased
405,120
-14.2%
$947,9820.0%$2.38
0
2025-Q2
Decreased
472,042
-3.7%
$717,5040.0%$1.57
0
2025-Q1
Increased
490,200
+12.8%
$678,9270.0%$1.55
28
2024-Q4
Increased
434,557
+1808.1%
$986,4440.0%$2.24
40
2024-Q3
Decreased
22,774
-66.8%
$107,4930.0%$4.26
0

Other major holders of CABA: BlackRock Finance, Inc., FRED ALGER MANAGEMENT, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used